Mizuho Forecasts Strong Price Appreciation for Cardinal Health (NYSE:CAH) Stock

Cardinal Health (NYSE:CAH) had its price objective raised by equities research analysts at Mizuho from $142.00 to $150.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Mizuho’s price objective points to a potential upside of 9.95% from the stock’s previous close.

Several other equities analysts also recently weighed in on CAH. Argus set a $148.00 target price on shares of Cardinal Health in a research note on Tuesday, February 4th. Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $132.00 to $145.00 in a research report on Monday, January 6th. JPMorgan Chase & Co. raised their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Wells Fargo & Company lifted their target price on shares of Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 4th. Finally, TD Cowen raised shares of Cardinal Health from a “hold” rating to a “buy” rating and increased their price target for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th. Four analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $140.14.

Cardinal Health Stock Down 0.2 %

Shares of CAH stock opened at $136.43 on Monday. The firm has a market cap of $32.96 billion, a P/E ratio of 25.45, a PEG ratio of 1.49 and a beta of 0.66. The company has a 50 day moving average of $128.36 and a 200-day moving average of $120.86. Cardinal Health has a 12-month low of $93.17 and a 12-month high of $137.18.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, equities analysts expect that Cardinal Health will post 7.95 EPS for the current year.

Institutional Investors Weigh In On Cardinal Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Cardinal Health by 35.2% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company’s stock valued at $3,871,000 after acquiring an additional 8,471 shares during the last quarter. CHURCHILL MANAGEMENT Corp raised its position in Cardinal Health by 1.5% during the 4th quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company’s stock valued at $28,435,000 after purchasing an additional 3,576 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Cardinal Health by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock worth $633,298,000 after buying an additional 42,082 shares during the period. Consolidated Planning Corp grew its position in shares of Cardinal Health by 40.0% in the 4th quarter. Consolidated Planning Corp now owns 8,926 shares of the company’s stock worth $1,056,000 after buying an additional 2,552 shares during the last quarter. Finally, Flputnam Investment Management Co. increased its stake in shares of Cardinal Health by 1.8% during the fourth quarter. Flputnam Investment Management Co. now owns 180,586 shares of the company’s stock valued at $21,358,000 after buying an additional 3,148 shares during the period. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.